GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mytrex Health Technologies Inc (ROCO:4431) » Definitions » Change In Receivables

Mytrex Health Technologies (ROCO:4431) Change In Receivables : NT$-42 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Mytrex Health Technologies Change In Receivables?

Mytrex Health Technologies's change in receivables for the quarter that ended in Dec. 2023 was NT$-54 Mil. It means Mytrex Health Technologies's Accounts Receivable increased by NT$54 Mil from Jun. 2023 to Dec. 2023 .

Mytrex Health Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was NT$-42 Mil. It means Mytrex Health Technologies's Accounts Receivable increased by NT$42 Mil from Dec. 2022 to Dec. 2023 .

Mytrex Health Technologies's Accounts Receivable for the quarter that ended in Dec. 2023 was NT$159 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mytrex Health Technologies's Days Sales Outstanding for the six months ended in Dec. 2023 was 43.47.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mytrex Health Technologies's liquidation value for the six months ended in Dec. 2023 was NT$-119 Mil.


Mytrex Health Technologies Change In Receivables Historical Data

The historical data trend for Mytrex Health Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mytrex Health Technologies Change In Receivables Chart

Mytrex Health Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.11 -51.50 69.50 20.69 -42.12

Mytrex Health Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.55 -8.32 29.00 11.98 -54.10

Mytrex Health Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mytrex Health Technologies  (ROCO:4431) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Mytrex Health Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=158.742/666.512*91
=43.47

2. In Ben Graham's calculation of liquidation value, Mytrex Health Technologies's accounts receivable are only considered to be worth 75% of book value:

Mytrex Health Technologies's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=240.749-580.718+0.75 * 158.742+0.5 * 203.222
=-119

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mytrex Health Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Mytrex Health Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Mytrex Health Technologies (ROCO:4431) Business Description

Traded in Other Exchanges
N/A
Address
No. 545, Sec. 2, Hezun North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.

Mytrex Health Technologies (ROCO:4431) Headlines

No Headlines